Literature DB >> 32531292

AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders.

Geoffrey A Preidis1, Adam V Weizman2, Purna C Kashyap3, Rebecca L Morgan4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32531292      PMCID: PMC8018518          DOI: 10.1053/j.gastro.2020.05.060

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  293 in total

1.  A randomized controlled trial to evaluate the efficacy of lactobacillus GG in infantile diarrhea.

Authors:  Sudipta Misra; Tapas K Sabui; Nishith K Pal
Journal:  J Pediatr       Date:  2009-07       Impact factor: 4.406

2.  Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.

Authors:  S Guglielmetti; D Mora; M Gschwender; K Popp
Journal:  Aliment Pharmacol Ther       Date:  2011-03-21       Impact factor: 8.171

3.  An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea.

Authors:  Vanessa Liévin-Le Moal; Luis E Sarrazin-Davila; Alain L Servin
Journal:  Pediatrics       Date:  2007-09-03       Impact factor: 7.124

4.  A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a randomised controlled trial.

Authors:  Samford Wong; Ali Jamous; Jean O'Driscoll; Ravi Sekhar; Mike Weldon; Chi Y Yau; Shashivadan P Hirani; George Grimble; Alastair Forbes
Journal:  Br J Nutr       Date:  2013-09-18       Impact factor: 3.718

5.  A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.

Authors:  S Drouault-Holowacz; S Bieuvelet; A Burckel; M Cazaubiel; X Dray; P Marteau
Journal:  Gastroenterol Clin Biol       Date:  2008-03-04

6.  Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome.

Authors:  Dong Hyun Sinn; Ji Hyun Song; Hoi Jin Kim; Jun Haeng Lee; Hee Jung Son; Dong Kyung Chang; Young-Ho Kim; Jae J Kim; Jong Chul Rhee; Poong-Lyul Rhee
Journal:  Dig Dis Sci       Date:  2008-02-15       Impact factor: 3.199

7.  Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.

Authors:  Philippe Ducrotté; Prabha Sawant; Venkataraman Jayanthi
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

8.  Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.

Authors:  Stephen J Allen; Kathie Wareham; Duolao Wang; Caroline Bradley; Hayley Hutchings; Wyn Harris; Anjan Dhar; Helga Brown; Alwyn Foden; Michael B Gravenor; Dietrich Mack
Journal:  Lancet       Date:  2013-08-08       Impact factor: 79.321

9.  Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study.

Authors:  Khin Htwe; Khin Saw Yee; Marlar Tin; Yvan Vandenplas
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

10.  Bifidobacterium and enteral feeding in preterm infants: cluster-randomized trial.

Authors:  Satsuki Totsu; Chika Yamasaki; Masaki Terahara; Atsushi Uchiyama; Satoshi Kusuda
Journal:  Pediatr Int       Date:  2014-06-17       Impact factor: 1.524

View more
  17 in total

1.  Probiotics Reduce Mortality and Morbidity in Preterm, Low-Birth-Weight Infants: A Systematic Review and Network Meta-analysis of Randomized Trials.

Authors:  Rebecca L Morgan; Geoffrey A Preidis; Purna C Kashyap; Adam V Weizman; Behnam Sadeghirad
Journal:  Gastroenterology       Date:  2020-06-24       Impact factor: 22.682

2.  N, O-codoped hierarchical porous graphitic carbon for electrochemical immunosensing of Lactobacillus rhamnosus GG.

Authors:  Yajun Gao; Jiamin Wang; Yitian Du; Chunsen Wu; Huaxiang Li; Zhenquan Yang; Zhiyan Chen; Zhanjun Yang
Journal:  Mikrochim Acta       Date:  2021-12-02       Impact factor: 5.833

Review 3.  The Gut Microbiome and Colonic Motility Disorders: A Practical Framework for the Gastroenterologist.

Authors:  Wenjie Ma; David A Drew; Kyle Staller
Journal:  Curr Gastroenterol Rep       Date:  2022-08-09

Review 4.  Microbiota on biotics: probiotics, prebiotics, and synbiotics to optimize growth and metabolism.

Authors:  Price T Edwards; Purna C Kashyap; Geoffrey A Preidis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-08-05       Impact factor: 4.052

Review 5.  The Microbiota-Gut-Brain Axis: From Motility to Mood.

Authors:  Kara G Margolis; John F Cryan; Emeran A Mayer
Journal:  Gastroenterology       Date:  2021-01-22       Impact factor: 22.682

Review 6.  Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.

Authors:  Mirae Lee; Eugene B Chang
Journal:  Gastroenterology       Date:  2020-11-27       Impact factor: 22.682

7.  Functional Gastrointestinal Disorders and the Microbiome-What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic?

Authors:  Ruben A T Mars; Mary Frith; Purna C Kashyap
Journal:  Gastroenterology       Date:  2020-11-28       Impact factor: 22.682

Review 8.  Irritable bowel syndrome in midlife women: a narrative review.

Authors:  Pei-Lin Yang; Margaret M Heitkemper; Kendra J Kamp
Journal:  Womens Midlife Health       Date:  2021-05-31

Review 9.  Breast Milk: A Source of Functional Compounds with Potential Application in Nutrition and Therapy.

Authors:  Cristina Sánchez; Luis Franco; Patricia Regal; Alexandre Lamas; Alberto Cepeda; Cristina Fente
Journal:  Nutrients       Date:  2021-03-22       Impact factor: 5.717

Review 10.  Microbiome-immune interactions in tuberculosis.

Authors:  Giorgia Mori; Mark Morrison; Antje Blumenthal
Journal:  PLoS Pathog       Date:  2021-04-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.